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The anti-inflammatory and analgesic properties of the 85 % methanolic extract of Withania 
somnifera (WS) root was investigated and the anti-inflammatory effect was compared with the 
standard drug indomethacin. Analgesic activity was carried out by hot plate and tail flick method. 
Anti-inflammatory activity was carried out by carraggenan induced paw edema and Freund’s 
adjuvant induced arthritis. The results are related with evaluation of the analgesic activity in hot 
plate and tail flick method, they reveal that methanolic extract has exhibited significant activity 
(P<0.05) at 150 mg/kg b.wt, itself, whereas, the percentage inhibition exhibited by WS (350 mg/kg 
b.wt,) in carrageenan induced paw edema is found to be nearer to that of standard drug (10 mg/kg 
b.wt.). In Freund’s adjuvant induced arthritis, WS is seen to decrease the paw volume significantly 
(P<0.05). Significant (P<0.05) protection is also observed by elevating antioxidant enzymes. WS 
does not exhibit toxic effect which is observed in standard drug treatment. The 85 % crude 
methanolic extract does not present toxic effect as observed in indomethacin treatment. However, 
the extract has exhibited analgesic, anti-inflammatory and antioxidant activities. 
 
 




Withania somnifera Dunal (ashwagandha) is 
widely used in Ayurvedic medicine, a traditional 
medical system of India. It forms an ingredient in 
many formulations prescribed for a variety of 
musculoskeletal conditions (e.g., arthritis, 
rheumatism), and as a general tonic to increase 











energy, improve overall health and longevity. It is 
used to prevent disease among athletes and the 
elderly. Many pharmacological studies have 
been conducted to investigate the properties of 
ashwagandha in an attempt to authenticate its 
use as a multi-purpose medicinal agent [1] anti-
inflammatory properties [2], and anti-stress agent 
[3]. 
 
Anbalagan [4] has evaluated the anti-
inflammatory effect of dried root powder of 
Withania somnifera in Freund’s adjuvant induced 
inflammation. They have compared the effect of 
Withania somnifera with the standard drug of 
phenylbutazone. Moreover, they have confirmed 
that dried powder of Withania somnifera root 
(WS) is active against inflammation. Begum [5] 
has reported the anti-inflammatory activity of WS 
powder in carraggenan induced acute 
inflammation. Likewise, Begum [6] has evaluated 
the anti-inflammatory activity of WS powder in 
Freund’s adjuvant induced arthritis. In both the 
models, they have used dried powder of WS. In 
our study, we have evaluated the anti-
inflammatory activity of 85 % methanolic extract 
of WS in both carrageenan and Freund’s 
adjuvant induced arthritis at minimal dose and 
compared their efficacy with the standard drug 
Indomethacin. In the present study, we have also 
evaluated the analgesic effect of 85 % 
Methanolic extract of WS by hot plate and tail 
immersion method.  
 
2. MATERIALS AND METHODS 
 
2.1 Plant Material 
 
The roots of WS were collected from Madurai 
region, Tamilnadu, India. The plant was identified 
and authentified at Centre for Advanced 
Research in Indian System of Medicine 
(CARISM), SASTRA University, Thanjavur, 
Tamilnadu, India and the Specimen of the same 




The material was dried under shade. One kg of 
crushed root of the plant was soaked with seven 
liters of different solvents like hexane, 
chloroform, ethyl acetate and 85 % methanol for 
7 days. The extract was filtered and concentrated 
by distillation. The final traces of solvent were 
dried in a vacuum oven at 500C. The yield of 
extract was as follows: In hexane - 0.76 %, in 
chloroform – 1.34 %, in ethyl acetate – 1.32 %, in 
85 % methanol – 4.62 %. 
2.3 Qualitative Analysis of WS Extracted 
with Different Solvents 
 
Different extracts of WS were tested for the 
presence of various phytoconsitutents like 1) 
alkaloids using dragendroff, wagner and hager’s 
reagent. 2) Flavonoids using aqueous sodium 
hydroxide solution. 3) Polyphenolics using folin 
phenol reagent. 4) Phytosterol by Libermann 
Burchard test which was carried out by mixing 
extract with acetic acid, acetic anhydride and 
sulphuric acid, 5) Saponins by testing the extract 
for the formation of foam by agitating with 
distilled water. 6) Carbohydrate by Molisch test 
which was carried out by mixing extract with 
alcoholic α-naphthol solution and concentrated 
sulphuric acid solution. 7) Amino acids and 
proteins using ninhydrin, Molisch and biuret 
reagent.  
 
2.4 Experimental Animals 
 
In this study, 102 adult Wistar albino rats 
weighing 180–210 g, obtained from Centre for 
Advanced Research in Indian System of 
Medicine (CARISM), Animal house, SASTRA 
University, Tamilnadu, India were used. The rats 
were fed with standard laboratory chow and 
sterile water before the experiment. The animal 
laboratory was equipped with automatic 
temperature (22 ± 1
0
C) and lighting controls (12 
h light/12 h dark).  
 
2.5 Experimental Protocol for Analgesic 
Activity  
 
In the Hotplate test [7] rats were divided in to 
different groups as follows. Each group consists 
of six animals. Group I - Control animals – 5% 
Tween 80 in water, Group II- Treatment 1- 150 
mg/kg b.wt. extract, Group III- Treatment II- 250 
mg/kg b.wt. Extract, Group IV- Treatment III - 
350 mg/kg b.wt. Extract. Four experimental 
groups were used. Rats treated with saline 
solution were employed as controls. The 
experimental groups were treated with WS (150, 
250 and 350 mg/kg b.wt, p.o.). In this test, 
animals were individually placed on a hot plate 
maintained at a constant temperature 
(55+0.3oC). The latency to first sign of hind paw 
licking or jump response to avoid heat 
nociception was taken as an index of nociceptive 
threshold with cut off time of 15 sec. The 
nociceptive threshold was observed every 60 min 












2.6 Experimental Protocol for Analgesic 
Activity  
 
In the Tail immersion method [8] rats were 
divided in to different groups as follows. Each 
group consists of six animals. Group I - Control 
animals – 5 % Tween 80 in water), Group II - 
Treatment 1- 150 mg/kg b.wt. extract, Group III
 - Treatment II - 250 mg/kg b.wt.extract 
Group IV- Treatment III- 350 mg/kg b.wt. extract. 
The antinociceptive effect was determined in rats 
using the tail-flick test by analgesiometer. The 
responses were elicited every 15 min up to 60 
min after treatment, with WS under study and the 
vehicle. Four experimental groups were used. 
Rats treated with saline solution were employed 
as controls. The experimental groups were 
treated with WS (150,250 and 350 mg/kg p.o.) 
 
2.7 Experimental protocol for 
Carrageenan induced inflammation 
 
Anti-inflammatory effects of 85 % methanolic 
extract of WS was investigated which was 
induced by carrageenan [9,10]. The animals 
were divided in to following groups as follows. 
Group I- Normal - 5% Tween 80 in water, Group 
II- Standard - 10 mg/kg b.wt. indomethacin, 
Group III - Treatment 1- 150 mg/kg b.wt. extract, 
Group IV- Treatment II - 250 mg/kg b.wt. extract, 
Group V- Treatment III - 350 mg/kg b.wt. extract. 
The anti-edematogenic properties of the WS 
extract was studied using the carrageenan-
induced edema model. Groups of six rats were 
used. Animals were given a saline solution, 
indomethacin (10 mg/kg b.wt, p.o) and a dose of 
a selected WS extract, 1 h before administration 
of an intradermal injection of carrageenan (0.1 ml 
of a 1% solution in 0.9% saline solution) into the 
plantar region of the right hind paw. The 
contralateral paw was injected with 0.1 ml saline 
solution. The group treated with the WS extract 
was injected with 150, 250 and 350 mg/kg b.wt, 
p.o. The paw volume was measured before the 
injection and each hour after for a period of 4 h 
by means of volume displacement methods. The 
difference between the left paw and the right paw 
volumes indicated the degree of inflammation. 
The average increase in paw volume of each 
group was calculated and compared with the 
control (saline) and the indomethacin groups.  
 
2.8 Experimental Protocol for Freund’s 
Adjuvant Induced Arthritis  
 
Animals were divided in to four groups as 
follows. Each group consists of six animals. 
Group I - Normal -5 % Tween 80 in water, Group 
II – Control - Complete Freund’s adjuvant (CFA), 
Groups III – Treatment - 250 mg/kg b.wt. extract 
+ CFA, Group IV – Treatment - 10 mg/kg b.wt. 
Indomethacin + CFA. The right foot pad of each 
rat was injected subcutaneously with 0.05 ml of 
Complete-Freund’s Adjuvant agent [11]. The 
animals were treated with extract and standard 
drug for 45 days. On 46
th
 day all the animals 
were sacrificed by cervical dislocation under 
ether anesthesia. Liver and kidney was excised 
and washed with saline. 10 % tissue 
homogenate was prepared in Tris buffer and 
various biochemical parameters like Thio 
barbituric acid Reactive Substances (TBARS) 
[12] Reduced Glutathione (GSH) [13], 
Gluatthione peroxidase (GPx) [14] and catalase 
[15] were estimated. 
 
2.9 Statistical Analysis 
 
The values have been expressed as Mean ± 
S.D. Significant difference have been observed 
using One Way Analysis of variance (ANOVA) by 
SPSS software version 12.0. P<0.05, was 
considered as significant difference. Groups 





3.1 Qualitative Analysis of WS Extracted 
with Different Solvents 
 
Qualitative analysis showed the presence of 
alkaloids in chloroform extract, phenols in 
Ethylacetate and 85 % methanolic extract and 
phytosterol, saponin and carbohydrates in 85 % 
methanolic extract can be seem Table 1. 
 
3.2 Analgesic Activity (Hot Plate Method 
and Tail Immersion Method) 
 
In our present study maximum anti-nociceptive 
effect of methanolic extract in hot plate method 
was observed at 3rd hour by the dose of 250 
mg/kg b.wt. (P<0.05, Table 2). Moreover, 
significant difference has been observed at 150 
mg/kg b.wt. of extract against 0 hour in hot plate 
test and also in tail immersion method in Table 2 
and 3. Significant difference has not been 
observed by increasing the dose of the extract 
against lower dose treated animals. 
 
3.3 Carrageenan Induced Inflammation 
 
85 % Methanolic extract treatment is found to 
decrease the carrageenan induced edematous 
paw volume significantly against Group I 
animals. The decrement is seen to be dose 
dependent. Neverthless, the percentage 
protection exhibited by extract at the dose of 350 
mg/kg b.wt is nearer to that of 10 mg/kg b.wt. of 
standard drug treatment. The resu
groups of rats can be seen in Table 4.
 
3.4 Freund’s Adjuvant Induced Arthri
 
The paw volume of Freund’s adjuvant 
administered animals is observed to be 
decreased by treating animals with extract. 
Animals treated with extract at the dose of 250 
Table 1.  Qualitative analysis of 
Phyto-constituents Hexane
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Fig. 1. %Effect of Withania somnifera
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mg/kg b.wt. for 45 days exhibit similar activity as 
that of Indomethacin at the dose of 1
b.wt in Table 5. TBARS level in liver tissue of 
Freund’s adjuvant administered rats is noticed to 
increased in diseased rats (P<0.05, Table 6). 
Treatment with extract for 45 days is seen to 
return back the TBARS level to normal level.  
Indomethacin administration has elevated the 
level of TBARS in kidney tissue in Fig 1. The 
antioxidants like GSH, GPx and catalase of 
treated rats have indicated the increase against 
Freund’s adjuvant administered animals can be 
seen in Table 6 (P<0.05).  
 
Withania somnifera extracted with different solvents
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Table 2.  Anti-nociceptive effect of Withania somnifera in hot plate test 
 
Groups Dose                            Reaction time in hour 
0 hr 1 hr 2 hr 3 hr 4 hr 
                         Response time in seconds 
Group I  - 3.1  0.90  3.1  1.50 3.8  0.96 3.1  0.30 4.8  0.50 
Group II WS  
150 mg/kg 
3.6  0.90 a  6.1  1.40 c 6.6  1.80 cd 7.3  3.30 d 5.4  0.50 b  
Group III WS 
250 mg/kg 
3.1  0.50 a  4.5  1.20 ab 5.0  1.50 b 8.5  2.60 c 4.5  0.90 ab 
Group IV WS 
350 mg/kg 
2.1  0.30 a  4.5  1.30 b 3.9  0.80 b 6.6  3.60 d  5.4  0.40 c 
Values are Mean  SD. One Way ANOVA was carried out using SPSS software version 12.0. Significant difference (P<0.05) has been observed between 0 hour and different 
hours of the same group. Values not sharing common alphabets are differ significantly at P<0.05 
 
Table 3.  Anti-nociceptive effect of Withania somnifera in tail immersion test 
 
Drug Dose                       Response time in sec. 
 Reaction time in min. 0 min. 15 min. 30 min. 45 min. 60 min. 
Group I  - 4.3  0.50 4.0  0.80 3.8  0.50 5.3  0.96 4.0  0.80 
Group II WS 
150 mg/kg 
2.0  0.0 a 3.3  0.50 b 3.6  0.80  b 3.4  0.50 b 3.6  0.50 b 
Group III WS 
250 mg/kg 
2.8  0.30 a 3.6  0.50 b 3.9  0.30 b 3.4  0.30 b 3.0  0.80 b 
Group IV WS 
350 mg/kg 
2.5  0.60 a 2.9  0.30 ab 3.1  0.30 ab 3.8  0.60 b 3.4  0.50 b 
Values are Mean  SD. One Way ANOVA was carried out using SPSS software version 12.0. Significant difference (P<0.05) has been observed between 0 hour and different 



















Table 4. Effect of Withania somnifera in Carrageenan Induced Rat Paw Edema 
 
Groups Dose mg/kg b.w Increase in Paw edema 
( Mean ± SD) in mm 
% Inhibition of Paw 
edema 
Group I 5 % Tween 80 2.00± 0.14 c - 
Group II Indomethacin 10 0.99± 0.10 a 50.20 
Group III WS 150 1.42± 0.13 b 29.05 
Group IV WS 250 1.46± 0.06 b 26.93 
Group V WS 350 0.96± 0.05 a 52.13 
Values are Mean  SD. One Way ANOVA was carried out using SPSS software version 12.0. Significant 
difference (P<0.05) has been observed between different groups. Values not sharing common alphabets are 
differ significantly at P<0.05 
 
















1 4.27±0.08 4.32±0.11 a - 3.97±0.14 a - 
8 6.3±0.43 6.2±0.33 bc 1.59 6.3±0.34 c - 
15 6.68±0.51 6.38±0.41 c 4.49 5.98±0.38 c 10.75 
22 6.7±0.87 6.08±0.25 b 9.25 5.8±0.24 b 18.31 
29 6.7±0.46 5.85±0.19 b 12.69 5.03±0.22 b 22.62 
36 6.63±0.32 4.78±0.19 a 27.90 4.48±0.21 a 31.08 
43 6.45±0.39 4.52±0.11 a 29.92 4.35±0.05 a 32.03 
Values are Mean  SD. One Way ANOVA was carried out using SPSS software version 12.0. Significant 
difference (P<0.05) has been observed between different groups. Values not sharing common alphabets are 
differ significantly at P<0.05 
 
Table 6.  Effect of Withania somnifera in Freund’s Adjuvant Induced Oxidative stress 
 
Parameters Organs                                              Groups 
Normal Freund’s 
adjuvant 
Freund’s adjuvant + 
WS (250 mg/kg b.wt.) 
TBARS 
(nmoles/mg protein) 
Liver 1.19 ± 0.08 a 1.57 ± 0.18 b 1.14 ± 0.24 a 
Kidney 1.18 ± 0.05 a 1.23 ± 0.13 a 1.14 ± 0.09 a 
GSH 
(µg of GSH/mg 
protein) 
Liver 38.03 ± 7.49 b 23.27 ± 1.24 a 39.9 ± 8.72 b 
Kidney 40.99 ± 3.3 b 35.36 ± 2.4 b 27.96 ± 5.52 a 
Catalase 
(mM of H2O2 
consumed/ 
minute/mg protein) 
Liver 19.28 ± 1.41 b 13.84 ± 1.42 a 18.88 ± 1.74 b 
Kidney 19.34 ± 1.38 a 15.61 ± 1.04 b 17.41 ± 1.56 ab 
GPx 
(μg of GSH 
utilized/min /mg 
protein) 
Liver 0.153 ± 0.02 b 0.104 ± 0.0009 a 0.156 ± 0.0003 b 
Kidney 0.1091 ± 0.0011 a 0.1087 ± 0.0002 a 0.1092 ± 0.0005 a 
Values are Mean  SD. One Way ANOVA was carried out using SPSS software version 12.0. Significant 
difference (P<0.05) has been observed between different groups. Values not sharing common alphabets are 
differ significantly at P<0.05 
.  
4. DISCUSSION  
 
Pain and edema are the outcome of 
inflammatory reaction. Pain has been described 
as nature’s early sign of morbidity. It is reported 
that chemical production of pain usually results in 
an inflammatory response in biologically active 
system [16]. In our present study, we have 
assessed both the analgesic and anti-











Different extracts of WS have been taken to 
account the presence of various 
phytoconstituents in different extracts so as to 
choose the particular extract having the presence 
of maximum phytoconstituents for further study. 
Since most of the phyto-constituents are eluted 
out in the 85 % methanolic extract (Table 1), we 
have used the same for further pharmacological 
evaluation. 
 
Significant difference has been observed at 150 
mg/kg b.wt. (P<0.05) of extract against 0-hour 
response reveals that the extract is more potent 
at minimum dose itself (Table 2). Significant 
difference has not been noted down between 
Group II against Group III and IV. It directs that 
maximum activity is at minimum dose. However, 
it should be further evaluated by carrying out the 
bioavailability and pharmacokinetics study of the 
extract. Likewise, in tail immersion method 
maximum effect is observed at 150 mg/kg b.wt. 
of extract (Table 3) pointing out that the 
antinociceptive effect of WS is present at 150 
mg/kg b.wt. itself. It is reported that stimulation of 
sympathetic nerves is responsible for production 
of pain [17] Although the direct mechanism of 
action is still not established, the antinociceptive 
effect of WS might be due to the suppression of 
sympathoimetic amines. Antinociceptive effect of 
WS might be due to the presence of phenolic 
compounds. Phenolic compounds are reported to 
have analgesic activity through inhibition of the 
enzyme prostaglandin synthatase more 
specifically the endoperoxidase [18] Carrageenan 
induced edema model is a better model to 
assess anti-inflammatory activity of substances 
[9]. Hence the same method is adopted in our 
study.  
 
The development of edema in the paw of the rat 
after the injection of carrageenan is due to 
release of histamine, serotonin and prostaglandin 
like substances [19]. WS is able to suppress 
edema and this effect may be due to the 
inhibitory effects on the release of histamine, 5 – 
hydroxyl tryptamine and kinin like substances 
which are reported to release from mast cell 
degradation during first hour of carrageenan 
induced artificial paw edema [20]. This 
decrement of paw volume might be due to the 
presence of phenolic compounds in the extract. 
Compounds like phenolic compounds and 
flavonoids are reported to produce anti-
inflammatory action by decreasing capillary 
permeability [21].  
 
Bhatia [22] has mentioned that hydrogen 
sulphide synthesizing enzyme level is noted to 
be increased along with the paw volume. The 
significant decrease of paw volume of WS might 
be due to their effect on hydrogen sulphide 
synthesizing enzyme which should be evaluated 
further. Freund's adjuvant, prepared from certain 
heat-killed species of Mycobacteria by dispersion 
in mineral oil alone (i.e. no emulsifier), induces a 
chronic polyarthritis in 10 days or more after 
being injected in the footpad or tail or ears of 
sensitive rat strains [11]. Chatterjee [23] has 
mentioned that inhibition of adjuvant induced 
arthritis in rats is one of the most suitable test 
procedures to screen anti-arthritic agents since it 
closely resembles WS root to arthritic animals 
has resulted in the suppression of generalized 
immunological response to the constituents of 
the tubercle bacilli which become disseminated 
after administration in the sub-plantar region.  
  
Freund’s adjuvant disease is a complicated one 
due to the involvement of many organs other 
than the joints, notably the liver, bone marrow, 
spleen, etc. This made us to evaluate the effect 
of extract in Freund’s adjuvant affected organs 
other than joints like liver and kidney [24]. A 
major systemic event that occurs in the rat 
following the induction of inflammation is the 
marked alteration in the cellular defence 
mechanism. Many cellular defence mechanisms 
are directed against the toxic effects of these 
radicals in inflammatory process. TBARS which 
is formed as an end product for these toxic 
effects has been quantified in our present study. 
The decrement of TBARS observed by treatment 
has been suspected as the effect of antioxidant 
activity of WS. Anti-lipid peroxidative activity of 
WS has been reported earlier by Dhuley 
[25,26,27] 
 
To reconfirm the antioxidant activity various 
antioxidants like Glutathione, catalase and 
glutathione peroxidase level are also estimated. 
GSH level is found to be decreased significantly 
in liver tissue of diseased rats against normal 
(P<0.05, Table 6). This non-enzymatic 
antioxidant is observed to be increased by 
treatment. Effect of WS in increasing the level of 
GSH has been reported earlier by Singh [3].  In 
kidney tissue, the treatment is kept to be 
decreased (Table 6). This might be due to the 
mobilization of GSH from kidney to protect the 
animal from damage caused by Freund’s 
adjuvant.  
 
Catalase and GPx levels of both liver and kidney 
homogenate is found to decrease significantly in 











due to the utilization of enzymes by the diseased 
animals to protect the organ from damage 
caused by Freund’s adjuvant. Treatment with 
extract is acted to bring back the level of these 
enzymes to normal level. This might be due to 
the antioxidant effect of WS. The increasing 
catalase and GPx by WS might be due to the 
presence of glycowithanolides [3]. 
 
Fig. 1 reflects the better effect of WS than the 
standard drug Indomethacin. Administration of 
Indomethacin for a longer duration (10 mg/kg 
b.wt. for 45 days) is reported to develop lipid 
peroxidation of kidney. The toxic effect of 
indomethacin has been recorded earlier by 
Hemieda [28,29]. The toxic effect is not seen in 
WS treatment. This result reflects that WS 
treatment prevail better protection in anti-arthritic 
and anti-inflammatory effect without toxic effect. 
Likewise, the antioxidants like GSH (71.5 %), 
GPx (50.0 %) levels are found to get increased 
drastically in the liver homogenate by treating 
animals with WS. Indomethacin administration is 
recorded to increase these GSH and GPx level 
only by 9.6 % and 31.9 %, respectively. These 
results reveal that WS extract treatment is 
exhibiting better activity when compared to 




In conclusion, 85 % methanolic extract of WS 
exhibits antinociceptive effect at the lower dose 
and anti-inflammatory activity in carrageenan 
induced paw inflammation at the lower dose. 
Moreover, the anti-inflammatory activity exhibited 
by extract is nearer to that of standard drug 
Indomethacin. Treating Freund’s adjuvant 
induced arthritic animals of extract for 45 days is 
found to decrease the paw volume. The paw 
volume decrement of extract treatment is looked 
to be similar to that of Standard drug 
indomethacin. Further, Indomethacin drug 
treatment is seen to develop a toxic effect in 
kidney which is reflected in the level of TBARS. 
Similar toxic effects have not been observed by 
extract and the same dose of extract increased 
the level of antioxidants comparatively better 
than that of Indomethacin. It reflects that 85 % 
methanolic extract of WS treatment aid better 
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